Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia

202039 citationsJournal Articlegreen Open Access

Authors

Nicola Frei · Academic Medical Center

Amir M. Khoshiwal · Academic Medical Center

Kadère Konté · Academic Medical Center

Emily A. Bossart · Cernostics (United States)

Katelyn Stebbins · Cernostics (United States)

Yi Zhang · Cernostics (United States)

Roos E. Pouw ·

Abstract

The risk prediction assay provided significant risk stratification in BE patients with LGD and identified progressors that the experts downstaged to NDBE. This objective assay provides an effective solution to the lack of standardization of expert pathology review of LGD.

Topics & Keywords

Esophageal Cancer Research and Treatment Esophageal and GI Pathology Gastric Cancer Management and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The American Journal of Gastroenterology

Volume 116, Issue 4, pp. 675-682

DOI: 10.14309/ajg.0000000000001037

Field-Weighted Citation Impact: 5.10